Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.
Morales JM, Hartmann A, Walker R, Arns W, Senatorski G, Grinyó JM, Shoker A, Wilczek H, Jamieson NV, Lelong M, Brault Y, Burke JT, Scarola JA; Rapamune Maintenance Regimen Study Group. Morales JM, et al. Among authors: lelong m. Transplant Proc. 2009 Jul-Aug;41(6):2339-44. doi: 10.1016/j.transproceed.2009.05.009. Transplant Proc. 2009. PMID: 19715914
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group. Russ G, et al. Among authors: lelong m. Transplantation. 2005 Nov 15;80(9):1204-11. doi: 10.1097/01.tp.0000178393.78084.9b. Transplantation. 2005. PMID: 16314787 Clinical Trial.
Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF; Rapamune Maintenance Regimen Study Group. Legendre C, et al. Among authors: lelong m. Clin Transplant. 2007 May-Jun;21(3):330-6. doi: 10.1111/j.1399-0012.2007.00645.x. Clin Transplant. 2007. PMID: 17488381 Clinical Trial.
Pulmonary and systemic effects of inhaled crystalline silica in the HOCl-induced mouse model of systemic sclerosis: An experimental model of Erasmus syndrome.
Morin L, Zimmermann F, Lelong M, Ferrant J, Hemon P, Patry S, Tallec ELE, Uwambayinema F, Yakoub Y, Dumontet E, Huaux F, Lescoat A, Lecureur V. Morin L, et al. Among authors: lelong m. Clin Immunol. 2024 Dec 26:110423. doi: 10.1016/j.clim.2024.110423. Online ahead of print. Clin Immunol. 2024. PMID: 39732270
Effects of different amosite preparations on macrophages, lung damages, and autoimmunity.
Lescoat A, Leinardi R, Pouxvielh K, Yakoub Y, Lelong M, Pochet A, Dumontet E, Bellamri N, Le Tallec E, Pavan C, Turci F, Paris C, Huaux F, Lecureur V. Lescoat A, et al. Among authors: lelong m. J Mol Med (Berl). 2024 Feb;102(2):197-211. doi: 10.1007/s00109-023-02401-9. Epub 2023 Nov 28. J Mol Med (Berl). 2024. PMID: 38015242 Free article.
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Lelong M, Josien R, Coste-Burel M, Rimbert M, Bressollette-Bodin C, Nancey S, Bouguen G, Allez M, Serrero M, Caillo L, Rouillon C, Blanc P, Laharie D, Olivier R, Peyrin-Biroulet L, Dib N, De Maissin A, Montuclard C, Trang-Poisson C, Vavasseur F, Gallot G, Berthome M, Braudeau C, Chevreuil J, Bourreille A, Le Berre C. Lelong M, et al. Front Immunol. 2023 Aug 28;14:1243898. doi: 10.3389/fimmu.2023.1243898. eCollection 2023. Front Immunol. 2023. PMID: 37701431 Free PMC article.
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis.
Bellamri N, Lelong M, Joannes A, Le Tallec E, Jouneau S, Vernhet L, Lescoat A, Lecureur V. Bellamri N, et al. Among authors: lelong m. Int Immunopharmacol. 2023 Mar;116:109723. doi: 10.1016/j.intimp.2023.109723. Epub 2023 Jan 23. Int Immunopharmacol. 2023. PMID: 36696855 Free article.
380 results